- Senior Investigator, Section for Translational Research on Retinal and Macular Degeneration
Paul Sieving received his M.D. from the University of Illinois in 1978 and trained in ophthalmology at that institution between 1978 and 1982. He earned a Ph.D. in bioengineering from the University of Illinois in 1981. He was a faculty member at the University of Michigan Medical School for 17 years and moved to NIH in 2001. He combines laboratory research with clinical patient studies of genetic retinal neurodegenerative diseases. He is a member of the Institute of Medicine and currently serves as director of the National Eye Institute.
- (2019). Cone ERG Changes During Light Adaptation in Two All-Cone Mutant Mice: Implications for Rod-Cone Pathway Interactions. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 60(10), 3680-3688.
- (2019). Cryo-EM of retinoschisin branched networks suggests an intercellular adhesive scaffold in the retina. JOURNAL OF CELL BIOLOGY. 218(3), 1027-1038.
- (2019). Motivations and Decision Making Processes of Men With X-linked Retinoschisis Considering Participation in an Ocular Gene Therapy Trial. AMERICAN JOURNAL OF OPHTHALMOLOGY. 204, 90-96.
- (2019). The NIH Blueprint for Neuroscience Research Seeks Community Input on Future Neuroscience Investments. JOURNAL OF NEUROSCIENCE. 39(5), 774-775.
- (2019). Trans-ocular Electric Current In Vivo Enhances AAV-Mediated Retinal Gene Transduction after Intravitreal Vector Administration. Molecular Therapy-Methods & Clinical Development. 13, 77-85.